CANON INC-SPONS ADR (CAJ)       22.72  -0.02 (-0.09%)

22.72  -0.02 (-0.09%)

US1380063099 - ADR


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CAJ. CAJ was compared to 35 industry peers in the Technology Hardware, Storage & Peripherals industry. CAJ scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. A decent growth rate in combination with a cheap valuation! Better keep an eye on CAJ.




Profitability

Profitability Rating

2

CAJ's Profit Margin of 5.72% is in line with the rest of the industry. The industry average Profit Margin is 7.07%.
CAJ has a Piotroski-F score of 5.00. This indicates an average health and profitability for CAJ.

CAJ has a Return On Assets of 4.13%. This is below the industry average of 8.11%.
CAJ has a Return On Equity of 7.01%. This is below the industry average of 8.59%.
VS Industry

ROA (4.13%) VS Industry: 33% outperformed.

0.42
43.20

ROE (7.01%) VS Industry: 33% outperformed.

1.40
196.96

Profit Margin (5.72%) VS Industry: 44% outperformed.

0.51
38.86

Valuation

Valuation Rating

7

With a Forward Price/Earnings Ratio of 10.67, the valuation of CAJ can be described as very reasonable.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a price book ratio of 0.96, CAJ is valued rather cheaply.
Compared to an average industry price book ratio of 1.42, CAJ is valued rather cheaply

Compared to an average Enterprise Value to EBITDA ratio of 9.26, CAJ is valued rather cheaply. On top of this, CAJ has a better ratio than 85% of the companies listed in the same industry.
With a Price/Earnings Ratio of 13.85, CAJ is valued correctly.
Compared to an average industry Price/Earning Ratio of 13.85, CAJ is valued in line with its industry peers.
VS Industry

Price/Earnings (13.85) VS Industry: 50% outperformed.

143.30
1.64

Price/Book (0.96) VS Industry: 73% outperformed.

45.61
0.25

Enterprise Value/ EBITDA (4.82) VS Industry: 85% outperformed.

175.25
0.72

Growth

Growth Rating

6

Based on estimates for the next 5 years, CAJ will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.01% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
CAJ shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.86%.

CAJ shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 8.28% yearly.
CAJ shows a small growth in Revenue. In the last year, the Revenue has grown by 9.31%.
Measured over the past 5 years, CAJ shows a small growth in Revenue. The Revenue has been growing by 0.65% on average per year.
The Revenue is expected to grow by 5.73% on average over the next 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS8.28% -4.27% 5.86% 22.63% 15.53% 11.01% N/A
Revenue0.65% -3.85% 9.31% 12.78% 7.61% 5.73% N/A

Health

Health Rating

6

CAJ is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 2.14.
A Current Ratio of 1.71 indicates that CAJ should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.76.
A Quick Ratio of 1.05 indicates that CAJ should not have too much problems paying its short term obligations.

CAJ has a Quick Ratio comparable to the industry average, which is at 1.19.
Compared to an average industry Debt to Equity Ratio of 0.01, CAJ is more dependent on financing than its industry peers.
We won't put much weight on the industry comparison as CAJ has a very low Debt to Equity (0.06).
An Altman-Z score of 2.93 indicates that CAJ is not a great score, but indicates only limited risk for bankruptcy at the moment.
CAJ has a Piotroski-F score of 5.00. This indicates an average health and profitability for CAJ.
VS Industry

Debt/Equity (0.06) VS Industry: 39% outperformed.

1.99
0.00

Quick Ratio (1.05) VS Industry: 46% outperformed.

0.26
36.24

Current Ratio (1.71) VS Industry: 46% outperformed.

0.43
36.70

Altman-Z (2.93) VS Industry: 71% outperformed.

-7.17
17.58

Dividend

Dividend Rating

7

With a Yearly Dividend Yield of 4.04%, CAJ is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.29, CAJ pays a bit more dividend than its industry peers.
CAJ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.

CAJ has been paying a dividend for at least 10 years, so it has a reliable track record.
CAJ pays out 54.51% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CAJ decreases each year by -14.50%.
VS Industry

Dividend Yield (4.04%) VS Industry: 77% outperformed.

0.67
6.04

CANON INC-SPONS ADR22.72

NYSE:CAJ (1/27/2023, 4:06:42 PM)-0.02 (-0.09%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Technology Hardware & Equipment
GICS Industry Technology Hardware, Storage & Peripherals
Earnings (Last) 10-26 2022-10-26/dmh Earnings (Next) 04-24 2023-04-24
Inst Owners 1.69% Inst Owner Change -0.57%
Ins Owners N/A Ins Owner Change N/A
Market Cap 23.07B Analysts 69.09
Price Target 27.2 (19.72%)

Dividend
Dividend Yield 4.04% Dividend Growth -14.5%
DP 54.51% Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -16.33%
Min EPS beat(2) -26.26% Max EPS beat(2) -6.4%
EPS beat(4) 1 Avg EPS beat(4) -7.74%
Min EPS beat(4) -26.26% Max EPS beat(4) 14.68%
Revenue beat(2) 1 Avg Revenue beat(2) -1.3%
Min Revenue beat(2) -5.04% Max Revenue beat(2) 2.45%
Revenue beat(4) 1 Avg Revenue beat(4) -2.81%
Min Revenue beat(4) -6.48% Max Revenue beat(4) 2.45%
PT rev (1m) 2.21% EPS NQ rev (1m) -0.77%
EPS NY rev (1m) -0.77% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 13.85
Fwd PE 10.67
P/S 0.78
P/FCF 29.06
P/OCF 10.34
P/B 0.96
P/tB 1.63
EV/EBITDA 4.82
EPS(TTM) 1.64 EY 7.22%
EPS(NY) 2.13 Fwd EY 9.37%
FCF(TTM) 0.78 FCFY 3.44%
OCF(TTM) 2.2 OCFY 9.67%
SpS 29.06 BVpS 23.7
TBVpS 13.98 PEG (NY) 0.61
PEG (5Y) 1.67

Profitability
Industry RankSector Rank
ROA 4.13%
ROE 7.01%
ROIC 5.91%
ROICexc 6.67%
ROICexgc 10.16%
OM 8.65%
PM 5.72%
GM 45.63%
ROICexgc(3y) 7.02% ROICexcg growth 3Y -6.15%
ROICexcg growth 5Y 4.92% ROICexc(3y) 4.33%
ROICexc growth 3Y -5.81% ROICexc growth 5Y 5.44%
OM growth 3Y -2.58% OM growth 5Y 3.59%
PM growth 3Y -1.5% PM growth 5Y 6.65%
GM growth 3Y -0.08% GM growth 5Y -1.2%
F-Score 5 Asset Turnover 0.72

Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 4.11
Debt/EBITDA 0.76
Cap/Depr 82.49%
Profit Quality 47.06%
Current Ratio 1.71
Quick Ratio 1.05
Altman-Z 2.93
F-Score 5 WACC 6.99%
ROIC/WACC 1.45 Cap/Depr(3y) 81.11%
Cap/Depr(5y) 78.36% Profit Quality(3y) 148.22%
Profit Quality(5y) 135.85%

Growth
EPS 1Y 5.86% EPS 3Y -4.27%
EPS 5Y 8.28% EPS growth Q2Q 12.11%
EPS Next Y 22.63% EPS Next 2Y 15.53%
EPS Next 3Y 11.01% EPS Next 5Y N/A
Revenue growth 1Y 9.31% Revenue growth 3Y -3.85%
Revenue growth 5Y 0.65% Revenue growth Q2Q 19.53%
Revenue Next Year 12.78% Revenue Next 2Y 7.61%
Revenue Next 3Y 5.73% Revenue Next 5Y N/A
EBIT growth 1Y 17.19% EBIT growth 3Y -6.32%
EBIT growth 5Y 4.26% EBIT Next Year 28174.7%
EBIT Next 3Y 570.94% EBIT Next 5Y N/A
FCF growth 1Y -40.67% FCF growth 3Y 16.32%
FCF growth 5Y -1.38% OCF growth 1Y -19.13%
OCF growth 3Y 7.28% OCF growth 5Y -2.05%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA